Avantor (ANT) Reports Q4 Earnings Decline Amid Higher Costs

Avantor, Inc (ANT) reported a decline in Q4 earnings on February 11, 2026, as higher supply chain and raw material costs offset gains from its biologics and life sciences solutions. The company posted revenue of $483.7 million, a 4.2% increase from the prior-year period, but earnings per share (EPS) fell to $0.36 vs. $0.41 in Q4 2024. Management attributed the earnings miss to inflation-driven input price increases and a shift in demand mix. The stock closed at $42.15 on the NYSE, down 2.8% in after-hours trading following the release.